Literature DB >> 16189655

Exon-1 polymorphism of ctla-4 gene is not associated with systemic sclerosis in Iranian patients.

A Rajaee1, A Ebrahimi, A Fotouhi Ghiam, T Kalantari, A Ghaderi.   

Abstract

Although, the cytotoxic T lymphocyte antigen-4 gene polymorphism at position 49 of exon-1 has been strongly elucidated in different autoimmune diseases, but its role in predisposition to systemic sclerosis (SSc) is yet controversial. This study intends to analyze the genetic correlation of the ctla-4 gene locus with diffuse systemic sclerosis (dSSc), as well as to understand the influence of these genotypes in disease expression. Seventy known cases of SSc, and 151 age-matched healthy controls, were participated in this investigation. The frequencies of AA, GG and AG genotypes were found to be 26 (37.1%), 5 (7.2%) and 39 (55.7%) in patients, and 60 (39.7%), 19 (12.6%) and 72 (47.7%) in controls, respectively. As indicated, the differences in genotype and allele frequencies between patients and controls were insignificant (P>0.05). Moreover, the distribution of CTLA-4 polymorphism between patients did not differ significantly according to clinical and serologic features. In Iranian patients, susceptibility to SSc is not influenced by a bi-allelic ctla-4 gene (A49G) polymorphism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16189655     DOI: 10.1007/s00296-005-0047-6

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  30 in total

1.  Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease.

Authors:  Hironori Ueda; Joanna M M Howson; Laura Esposito; Joanne Heward; Hywel Snook; Giselle Chamberlain; Daniel B Rainbow; Kara M D Hunter; Annabel N Smith; Gianfranco Di Genova; Mathias H Herr; Ingrid Dahlman; Felicity Payne; Deborah Smyth; Christopher Lowe; Rebecca C J Twells; Sarah Howlett; Barry Healy; Sarah Nutland; Helen E Rance; Vin Everett; Luc J Smink; Alex C Lam; Heather J Cordell; Neil M Walker; Cristina Bordin; John Hulme; Costantino Motzo; Francesco Cucca; J Fred Hess; Michael L Metzker; Jane Rogers; Simon Gregory; Amit Allahabadia; Ratnasingam Nithiyananthan; Eva Tuomilehto-Wolf; Jaakko Tuomilehto; Polly Bingley; Kathleen M Gillespie; Dag E Undlien; Kjersti S Rønningen; Cristian Guja; Constantin Ionescu-Tîrgovişte; David A Savage; A Peter Maxwell; Dennis J Carson; Chris C Patterson; Jayne A Franklyn; David G Clayton; Laurence B Peterson; Linda S Wicker; John A Todd; Stephen C L Gough
Journal:  Nature       Date:  2003-04-30       Impact factor: 49.962

2.  Increased expression levels of integrin alphavbeta5 on scleroderma fibroblasts.

Authors:  Yoshihide Asano; Hironobu Ihn; Kenichi Yamane; Masahide Kubo; Kunihiko Tamaki
Journal:  Am J Pathol       Date:  2004-04       Impact factor: 4.307

Review 3.  Epidemiology and natural history of systemic sclerosis.

Authors:  V D Steen; T A Medsger
Journal:  Rheum Dis Clin North Am       Date:  1990-02       Impact factor: 2.670

4.  Diffuse scleroderma occurring after the use of paclitaxel for ovarian cancer.

Authors:  R De Angelis; L Bugatti; A Cerioni; P Del Medico; G Filosa
Journal:  Clin Rheumatol       Date:  2003-02       Impact factor: 2.980

Review 5.  Systemic sclerosis: the susceptible host (genetics and environment).

Authors:  Filemon K Tan
Journal:  Rheum Dis Clin North Am       Date:  2003-05       Impact factor: 2.670

Review 6.  Scleroderma epidemiology.

Authors:  Maureen D Mayes
Journal:  Rheum Dis Clin North Am       Date:  2003-05       Impact factor: 2.670

Review 7.  CTLA-4 and its role in autoimmune thyroid disease.

Authors:  D A Chistiakov; R I Turakulov
Journal:  J Mol Endocrinol       Date:  2003-08       Impact factor: 5.098

8.  Cytotoxic T lymphocyte antigen-4 gene polymorphisms do not confer susceptibility to autoimmune hepatitis types 1 and 2 in Brazil.

Authors:  Paulo L Bittencourt; Selma A Palácios; Eduardo L R Cançado; Gilda Porta; Flair J Carrilho; Antonio A Laudanna; Jorge Kalil; Anna C Goldberg
Journal:  Am J Gastroenterol       Date:  2003-07       Impact factor: 10.864

Review 9.  Unravelling the genetic complexity of autoimmune thyroid disease: HLA, CTLA-4 and beyond.

Authors:  M J Simmonds; S C L Gough
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

10.  Association of CTLA-4 with systemic sclerosis in Japanese patients.

Authors:  F Takeuchi; K Kawasugi; H Nabeta; M Mori; K Tanimoto
Journal:  Clin Exp Rheumatol       Date:  2002 Nov-Dec       Impact factor: 4.473

View more
  2 in total

1.  Association of -318 C/T and +49 A/G cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms with a clinical subset of Italian patients with systemic sclerosis.

Authors:  G Balbi; F Ferrera; M Rizzi; P Piccioli; A Morabito; L Cardamone; M Ghio; G L Palmisano; P Carrara; S Pedemonte; M Sessarego; M De Angioletti; R Notaro; F Indiveri; M P Pistillo
Journal:  Clin Exp Immunol       Date:  2007-04-25       Impact factor: 4.330

2.  Elevated levels of CD4(+)CD25(+)FoxP3(+) T cells in systemic sclerosis patients contribute to the secretion of IL-17 and immunosuppression dysfunction.

Authors:  Xinjuan Liu; Na Gao; Mengtao Li; Dong Xu; Yong Hou; Qian Wang; Guohua Zhang; Qiuning Sun; Henghui Zhang; Xiaofeng Zeng
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.